Generalized glucocorticoid resistance accompanied with an adrenocortical adenoma and caused by a novel point mutation of human glucocorticoid receptor gene

Chinese Medical Journal

Volumn 124, Issue 4, 2011, Pages 551-555

  Zhu, Hui Juan ^a   Dai, Yu Fei ^a   Wang, Ou ^a   Li, Mei ^a   Lu, Lin ^a   Zhao, Wei Gang ^a   Xing, Xiao Ping ^a   Pan, Hui ^a   Li, Nai Shi ^a   Gong, Feng Ying ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Adrenal adenoma; Gene mutation; Generalized glucocorticoid resistance; Glucocorticoid receptor

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; GENOMIC DNA; GLUCOCORTICOID RECEPTOR ALPHA; HYDROCORTISONE; ISOLEUCINE; RNA; THREONINE;

ADRENAL CORTEX ADENOMA; ADRENAL INCIDENTALOMA; ADRENALECTOMY; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; ASYMPTOMATIC DISEASE; CASE REPORT; CHINA; CHROMOSOME; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DNA SEQUENCE; DRUG MEGADOSE; EXON; GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME; HETEROZYGOSITY; HORMONE RESISTANCE; HUMAN; HUMAN CELL; HYPERCORTISOLISM; LOW DRUG DOSE; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POINT MUTATION; PROTEIN DOMAIN;

ADRENOCORTICAL ADENOMA; DRUG RESISTANCE; ENDOCRINE SYSTEM DISEASES; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; RECEPTORS, GLUCOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79951791940     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.04.013     Document Type: Article

References (17)

1. Charmandari E, Kino T, Ichijo T, Chrousos GP. Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. J Clin Endocrinol Metab 2008; 93: 1563-1572.
2. Chrousos GP, Detera-Wadleigh SD, Karl M. Syndromes of glucocorticoid resistance. Ann Intern Med 1993; 119: 1113-1124.
3. Nader N, Bachrach BE, Hurt DE, Gajula S, Pittman A, Lescher R, et al. A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain. J Clin Endocrinol Metab 2010; 95: 2281-2285.
4. McMahon SK, Pretorius CJ, Ungerer JP, Salmon NJ, Conwell LS, Pearen MA, et al. Neonatal complete generalized glucocorticoid resistance and growth hormone deficiency caused by a novel homozygous mutation in Helix 12 of the ligand binding domain of the glucocorticoid receptor gene (NR3C1). J Clin Endocrinol Metab 2010; 95: 297-302.
5. Ashraf J, Thompson EB. Identification of the activation-labile gene: a single point mutation in the human glucocorticoid receptor presents as two distinct receptor phenotypes. Mol Endocrinol 1993; 7: 631-642.
6. Charmandari E, Kino T, Souvatzoglou E, Vottero A, Bhattacharyya N, Chrousos GP. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype. J Clin Endocrinol Metab 2004; 89: 1939-1949.
7. Karl M, Lamberts SW, Koper JW, Katz DA, Huizenga NE, Kino T, et al. Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians 1996; 108: 296-307.
8. Pujols L, Mullol J, Roca-Ferrer J, Torrego A, Xaubet A, Cidlowski JA, et al. Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. Am J Physiol Cell Physiol 2002; 283: C1324-C1331.
9. Weinberger C, Hollenberg SM, Rosenfeld MG, Evans RM. Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product. Nature 1985; 318: 670-672.
10. Bledsoe RK, Stewart EL, Pearce KH. Structure and function of the glucocorticoid receptor ligand binding domain. Vitam Horm 2004; 68: 49-91.
11. Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 2002; 110: 93-105.
12. Kino T, Vottero A, Charmandari E, Chrousos GP. Familial/sporadic glucocorticoid resistance syndrome and hypertension. Ann N Y Acad Sci 2002; 970: 101-111.
13. Charmandari E, Kino T, Chrousos GP. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms. Ann N Y Acad Sci 2004; 1024: 168-181.
14. Kino T, Stauber RH, Resau JH, Pavlakis GN, Chrousos GP. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking. J Clin Endocrinol Metab 2001; 86: 5600-5608.
15. Ruiz M, Lind U, Gafvels M, Eggertsen G, Carlstedt-Duke J, Nilsson L, et al. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol (Oxf) 2001; 55: 363-371.
16. Charmandari E, Raji A, Kino T, Ichijo T, Tiulpakov A, Zachman K, et al. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. J Clin Endocrinol Metab 2005; 90: 3696-3705.
17. Charmandari E, Kino T, Ichijo T, Jubiz W, Mejia L, Zachman K, et al. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance. J Clin Endocrinol Metab 2007; 92: 3986-3990.